Conference & Meetings World Supplements Canada Supplement | Page 11

Halifax
Ocean Nutrition Canada Limited
(ONC), founded in 1997, is a global
innovator and provider of quality
marine-based natural health and
nutrition products. ONC's primary
product focus is MEG-3® brand
Omega-3 EPA/DHA purified fish oil
ingredients for the global dietary
supplement and health food
ingredient markets.
The QEII Health Sciences Centre,
meanwhile, is the largest adult
academic health sciences centre
in Atlantic Canada and has the
highest number of certified clinical
research coordinators among
hospitals in North America.
BIOTIC (BIOmedical Translational
Imaging Centre) is a multi-site
centre embedded in the two
leading research and teaching
hospitals in Nova Scotia. Its teams
collaborate on commercial
development projects with industry
partners as well as R&D.
Business costs in Halifax are
competitive and there are many
incentives to invest and relocate.
Halifax is also competitive on
labour costs and has the lowest
average salary cost for each of the
six key positions.
Halifax has one of the highest
attendance rates in Canada
for meetings and conventions
and three recent successful
conferences at the end of
2018 included the International
Conference on Residency
Medicine for 700 delegates and
the Canadian Society of Club
Managers National Conference for
220 delegates, both in October,
and the Royal LePage National
Sales Conference, which drew
1,300 delegates in September.
Above:
Halifax has
one of the
highest
attendance
rates in
Canada for
meetings and
conventions
FAST FACTS:
• Nova Scotia is known as a
world leader in omega-3 fatty
acid supplements. Nature’s Way
Canada has the largest share of
Canada’s omega-3 market and
DSM Nutritional Products, located
in Mulgrave, Nova Scotia, is the
world's largest manufacturer of
concentrated fish oil.
• Acadian Seaplants is the world’s
largest independent manufacturer
of marine plant products and is
exporting to 80 countries.
• BioMedica Diagnostics is a
leader in the province’s large
medical technology area,
impacting patients in 60 countries.
• Immunovaccine Inc. is poised
to revolutionise immunotherapy
and has an estimated CAD$260m
market cap.
CONFERENCE & MEETINGS WORLD
11